Identifying Inhibitors of the APC/C Using Yeast Mutants

描述（由申请人提供）本研究的长期目标是利用酿酒酵母的突变体开发新型抗癌药物。研究的重点将是纺锤体检查点，它在有丝分裂中响应纺锤体和微管扰动而阻止细胞。微管蛋白是一种有效的抗癌化疗靶点。许多天然产物，如紫杉醇、长春碱和长春新碱，在单独或联合治疗时对广谱肿瘤有效。这些药物具有共同的作用机制;它们调节微管蛋白聚合成微管，从而激活纺锤体检查点。纺锤体检查点的目标是Cdc 20，其是将底物递送至后期促进复合物（APC/C）以进行泛素化和破坏的辅助因子。我们已经产生了APC/C和Cdc 20功能缺陷的酵母菌株，并建议继续筛选特异性抑制APCIC活性的化合物。我们建议进一步表征我们已经确定的六种化合物，并使用合理的药物设计来提高其有效性。我们将扩大分析，以确定它们是否影响APC/C功能和培养的人类细胞中的有丝分裂。我们将制备爪蟾卵母细胞和HeLa细胞的提取物，以确定APC/C活性的哪一步受到影响。我们将使用有序的定点突变体阵列进行系统的遗传分析，并确定纺锤体检查点突变体bub 3和所有缺乏非必需基因的突变体之间的合成致死相互作用。这将为西雅图项目在bub 3筛选中鉴定的化合物确定可能的细胞靶点。我们将表达由相互作用的基因编码的蛋白质，并确定它们是否与化合物结合。

DESCRIPTION (provided by applicant)The long-term goals of this research are to use mutants of the yeast Saccharomyces cerevisiae to develop novel anti-cancer drugs. The focus of the research will be the spindle checkpoint, which arrests cells in mitosis in response to spindle and microtubule perturbation. Tubulin is a validated target for anti-cancer chemotherapy. A number of natural products, such as taxol, vinblastine and vincristine are effective against a broad spectrum of tumors when used individually or in combination therapy. The drugs have a common mechanism of action; they modulate tubulin polymerization into microtubuies, which activates the spindle checkpoint. The target of the spindle checkpoint is Cdc20, an accessory factor that delivers substrates to the anaphase-promoting complex (APC/C) for ubiquitination and destruction. We have generated strains of yeast defective for APC/C and Cdc20 function and propose to continue screening for compounds that specifically inhibit APCIC activity. We propose to further characterize the six compounds that we haven already identified and to improve their effectiveness using rational drug design. We will expand the analysis to determine if they affect APC/C function and mitosis in cultured human cells. We will prepare extracts from Xenopus oocytes and HeLa cells to determine which step of APC/C activity is affected. We will use ordered arrays of site directed mutants to perform systematic genetic analysis and identify synthetic lethal interactions between a spindle checkpoint mutant, bub3, and all mutants that lack non-essential genes. This will identify possible cellular targets for compounds identified in a bub3 screen by the Seattle Project. We will express the proteins encoded by the interacting genes and determine if they bind the compounds.